Recent studies in autoimmune diseases suggest that increased expression of TLR2 in CD4+ T cells enhances immune reactivity and promotes IL-17 expression through upregulating H3K4 while downregulating H3K9 tri-methylation level in SLE (Liu et al., 2015). This evidence concerns the gene IL17A and systemic lupus erythematosus.